Anrotinib Hydrochloride
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anrotinib Hydrochloride, covering 2023-01-13 to 2023-01-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Multi-center Randomized Study to the Efficacy and Safety of AK105 Combined With Anrotinib Hydrochloride in Patients With Recurrent/Refractory Classical Hodgkin's Lymphoma [Phase 2]